US Stock MarketDetailed Quotes

ACTU Actuate Therapeutics

Watchlist

6.770
-0.280-3.97%

Close Dec 20 16:00 ET

6.770
0.0000.00%

Post 17:17 ET

132.23MMarket Cap-4.65P/E (TTM)

Actuate Therapeutics Stock Forum

Jaguar8

Dec 17 16:55

🟡Watchlist WEDNESDAY December 18,2024

NOTE!
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits
5. Always remember shorts include dark pools.
6. Most importantly, don’t blame for your losses. I already give watchlist and stock education. The ball is on you.
$KULR Technology (KULR.US)$ PR 12/17: Signs Service Agreement to Launch KULR ONE Space Battery. COH $13.4M good for 9 months✅
$Wearable Devices (WLDS.US)$ PR 12/17:...

Jaguar8

Dec 17 07:06

NEWS

$Actuate Therapeutics (ACTU.US)$
Actuate Therapeutics Announces Positive Interim Phase 2 Data of Elraglusib in First Line Treatment of Metastatic Pancreatic Cancer
Tuesday, 17th December at 8:00 am
• Statistical Significance Met on Primary Endpoints of 1 Year Survival Rate and Median Overall Survival
• Doubling of 1 Year Survival Rate and 37% Reduction in Risk of Death
• Two Month (29%) Increase in Median Overall Survival
• Multiple Patients with Complete Responses (CRs) and/or Partial Re...

BomBstar

Dec 16 03:57

$Actuate Therapeutics (ACTU.US)$ buy the dip?

Teddy123

Oct 29 22:55

Actuate to Participate in Lantern’s Pharma Webinar on AI-Driven Drug Development

$Actuate Therapeutics (ACTU.US)$
CHICAGO and FORT WORTH, Texas, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3β), announced that it will participate in “Webinar Wednesday” hosted b...